1. International Food Insight Council Foundation, Food & Health Survey 2015. 2015.
2. Food and Agriculture Organization of the United Nations, Fats and fatty acids in human nutrition: Report of an expert consultation. 2010: Rome.
3. Brenna, J.T., et al., alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins, Leukotrienes and Essential Fatty Acids. 80(2): p. 85-91.
4. Arterburn, L.M., E.B. Hall, and H. Oken, Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr, 2006. 83(6 Suppl): p. 1467S-1476S.
5. Chaddha, A. and K.A. Eagle, Cardiology Patient Page. Omega-3 Fatty Acids and Heart Health. Circulation, 2015. 132(22): p. e350-2.
6. Jacobson, T.A., et al., Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. J Clin Lipidol, 2012. 6(1): p. 5-18.
7. Miller, M., et al., Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation, 2011. 123(20): p. 2292-2333.
8. Weintraub, H., Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options. Atherosclerosis, 2013. 230(2): p. 381-9.
9. Weintraub, H.S., Overview of prescription omega-3 fatty acid products for hypertriglyceridemia. Postgrad Med, 2014. 126(7): p. 7-18.
10. Bureau of Nutritional Sciences; Food Directorate; Health Products and Food Branch, Summary of Health Canada's assessment of a health claim about eicosapentaenoic acid, docosahexaenoic acid and triglyceride lowering. 2016.
11. U.S. Department of Health and Human Services and U.S.D.o. Agriculture, 2015-2020 Dietary Guidelines for Americans. 2015.
12. Papanikolaou, Y., et al., U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003–2008. Nutrition Journal, 2014. 13: p. 31-31.
13. de Goede, J., et al., Marine (n-3) fatty acids, fish consumption, and the 10-year risk of fatal and nonfatal coronary heart disease in a large population of Dutch adults with low fish intake. J Nutr, 2010. 140(5): p. 1023-8.
14. Gonzalez-Rodriguez, L.G., et al., Omega 3 and omega 6 fatty acids intake and dietary sources in a representative sample of Spanish adults. Int J Vitam Nutr Res, 2013. 83(1): p. 36-47.
15. Kim, J., et al., Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer, 2009. 9: p. 216.
16. Joensen, A.M., et al., Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort study. Br J Nutr, 2010. 103(4): p. 602-7.
17. Raatz, S.K., et al., Issues of fish consumption for cardiovascular disease risk reduction. Nutrients, 2013. 5(4): p. 1081-97.
18. Salem, N., Jr. and M. Eggersdorfer, Is the world supply of omega-3 fatty acids adequate for optimal human nutrition? Curr Opin Clin Nutr Metab Care, 2015. 18(2): p. 147-54.
19. Borresen, T., ed. Improving Seafood Products for the Consumer. 2008, Woodhead Publishing Ltd: Cambridge, UK.
20. Miles, E.A. and P.C. Calder, Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood. Curr Pharm Des, 2014. 20(6): p. 946-53.
21. Lands, B., Consequences of essential fatty acids. Nutrients, 2012. 4(9): p. 1338-57.
22. Bibus, D. and B. Lands, Balancing proportions of competing omega-3 and omega-6 highly unsaturated fatty acids (HUFA) in tissue lipids. Prostaglandins Leukot Essent Fatty Acids, 2015. 99: p. 19-23.
23. Gomez Candela, C., L.M. Bermejo Lopez, and V. Loria Kohen, Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp, 2011. 26(2): p. 323-9.
24. Micha, R., et al., Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ, 2014. 348: p. g2272.
25. European Food Safety Authority, Scientific Opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDL-cholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentrations of triglycerides (ID 517), maintenance of normal LDL-cholesterol concentrations (ID 528, 698) and maintenance of joints (ID 503, 505, 507, 511, 518, 524, 526, 535, 537) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2009. 7(9): p. 1263.
26. European Food Safety Authority, Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal, 2012. 10(7): p. 2815.